NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Wiki Markup
{scrollbar:icons=false}

Page info
title
title

Example Files: 

Table of Contents
typeflat

This page provides examples for an example of the ISA-TAB-Nano Investigation files, File leveraging data from the Nanotechnology Characterization Laboratory (NCL) as an example (NCL200612A).The

ISA-TAB Investigation File

...

Extensions

  • ONTOLOGY SOURCE REFERENCE
  • INVESTIGATION
  • INVESTIGATION CONTACTS
  • INVESTIGATION PUBLICATION
  • STUDY
  • STUDY DESIGN DESCRIPTORS
  • STUDY CONTACTS
  • STUDY PUBLICATIONS
  • STUDY ASSAYS
  • STUDY FACTORS
  • STUDY PROTOCOLS

The ISA-TAB Investigation file was extended to support ISA-TAB-Nano.  TABLE 1 represents extensions made to each section of the ISA-TAB Investigation file in support of ISA-TAB-Nano.

...

Section

Field

Field Status (if applicable)

INVESTIGATION

Investigation Disease

Optional

INVESTIGATION

Investigation Disease Term Accession Number

Optional

INVESTIGATION

Investigation Disease Term Source REF

Optional

INVESTIGATION

Investigation Outcome

Optional

STUDY

Study Disease

Optional

STUDY

Study Disease Term Accession Number

Optional

STUDY

Study Disease Term Source REF

Optional

STUDY

Study Outcome

Optional

STUDY FACTORSStudy Factor Name Term Accessions NumberOptional
STUDY FACTORSStudy Factor Name Term Source REFOptional

STUDY ASSAYS

Study Assay Measurement Name

Optional

STUDY ASSAYS

Study Assay Measurement Name Term Accession Number

Optional

STUDY ASSAYS

Study Assay Measurement Name Term Source REF

Optional

 

Investigation File Example

The The sub-sections that follow identify the fields associated with each ISA-TAB -Nano Investigation File section.Investigation File consists of the following sections:

  • ONTOLOGY SOURCE REFERENCE
  • INVESTIGATION
  • INVESTIGATION CONTACTS
  • INVESTIGATION PUBLICATION
  • STUDY
  • STUDY DESIGN DESCRIPTORS
  • STUDY CONTACTS
  • STUDY PUBLICATIONS
  • STUDY ASSAYS
  • STUDY FACTORS
  • STUDY PROTOCOLS

An example of each section is provided below. 

Ontology Source Reference

TABLE 2: Example Investigation File Ontology Source Reference Section

ONTOLOGY   SOURCE REFERENCE                       
Term Source NameMONPOUOChEBIPATONCIt
Term Source Filehttp://purl.bioontology.org/ontology/MOhttp://purl.bioontology.org/ontology/npohttp://purl.bioontology.org/ontology/UOhttp://purl.bioontology.org/ontology/CHEBIhttp://purl.bioontology.org/ontology/PATOhttp://ncit.nci.nih.gov/
Term Source Versionv.1.3.1.1v.2011-02-12 v.80 v.11.11d
Term Source DescriptionMGED   OntologyNanoParticle   OntologyUnit   OntologyChemical   Entities of Biological InterestPhenotype   OntologyNCI Thesaurus

 

Investigation

TABLE 3: Example Investigation File Investigation Section

INVESTIGATION  
Investigation IdentifierNCL200612A
Investigation TitleDendrimer-Based   MRI Contrast Agents
Investigation DescriptionThe goal of this investigation is to characterize a PAMAM dendrimer with an associated gadolinium chelate MRI contrast agent.
Investigation Disease 
Investigation Disease Term Accession Number 
Investigation Disease Term Source REF 
Investigation Outcome 
Investigation Submission Date2002-11-30
Investigation Public Release Date2002-11-30

 

Investigation Contacts

TABLE 4: Example Investigation File Investigation Contacts Section

INVESTIGATION   CONTACTS 
Investigation Person Last NameMcNeil
Investigation Person First NameScott
Investigation Person Mid InitialsE
Investigation Person Emailmcneils@mail.nih.gov
Investigation Person Phone3018466939
Investigation Person Fax 
Investigation Person AddressMSC   1050 Boyles Street, Frederick, MD 21702
Investigation Person AffiliationNanotechnology   Characterization Laboratory
Investigation Person Rolesinvestigator
Investigation Person Roles Term Accession Number 
Investigation Person Roles Term Source REFMO

Investigation Publication

TABLE 5. Example Investigation Publication Section

INVESTIGATION   PUBLICATIONS 
Investigation PubMed ID18095846
Investigation Publication DOI10.2217/17435889.2.6.789  
Investigation Publication Author listHall JB; Dobrovolskaia MA; Patri AK; McNeil SE
Investigation Publication TitleCharacterization of nanoparticles for therapeutics
Investigation Publication Statuspublished
Investigation Publication Status Term Accession Number 
Investigation Publication Status Term Source REF 

Study

TABLE 6. Example Investigation File Study Section

STUDY 
Study IdentifierNCL200612A-CytoxicityLLC-PK1
Study TitleCytotoxicity characterization in LLC-PK1 cells
Study Submission Date2002-11-30
Study Public Release Date2002-11-30
Study DescriptionNanoparticle biocompatibility was evaluated in the porcine renal proximal tubule cell   line, LLC-PK1. Cytotoxicity was determined as described in the NCL protocol for LLC-PK1 Kidney Cytotoxicity Assay(GTA-1). Briefly, test materials were diluted to the desired assay concentrations in cell culture media. Cells were preincubated for 24 h prior to adding test material, reaching an approximate confluence of 80%. Cells were exposed to test material for 6, 24 and 48 h, and cytotoxicity was determined using the MTT cell viability and LDH membrane   integrity assays.
Study Disease 
Study Dise Term Accession Number 
Study Disease Term Source REF 
Study OutcomeNCL22, NCL23 and NCL24 were found to be minimally cytotoxic, under the testing   conditions utilized.
Study File Names_cytotoxicity-LLC-PK1.xls

Study Design Descriptors

TABLE 7. Example Investigation File Study Design Descriptors Section

STUDY   DESIGN DESCRIPTORS 
Study Design Typecomparison
Study Design Type Term Accession Number 
Study Design Type Term Source REF 

Study Contacts

TABLE 8. Example Investigation File Study Contacts Section

STUDY   CONTACTS 
Study Person Last NameDobrovolskaia
Study Person First NameMarina
Study Person Mid InitialsA
Study Person Emailmarina@mail.nih.gov
Study Person Phone3018466352
Study Person Fax 
Study Person AddressMSC 1050 Boyles Street, Frederick, MD 21702
Study Person AffiliationNanotechnology Characterization Laboratory
Study Person Rolesinvestigator
Study Person Roles Term Accession Number 
Study Person Roles Term Source REFMO

Study Publications

TABLE 9. Example Investigation File Study Publications Section

STUDY   PUBLICATIONS 
Study PubMed   ID18095846
Study Publication DOI10.2217/17435889.2.6.789  
Study Publication Author listHall JB; Dobrovolskaia MA; Patri AK; McNeil SE
Study Publication TitleCharacterization of nanoparticles for therapeutics
Study Publication Statuspublished
Study Publication Status Term Accession Number 
Study Publication Status Term Source REF 

Study Assays

TABLE 10. Example Investigation File Study Assays Section

STUDY   ASSAYS  
Study Assay Measurement TypeMTT AssayLDH Release Assay
Study Assay Measurement Type Term Accession Number NPO_1709
Study Assay Measurement Type Term Source REF NPO
Study Assay Technology Type  
Study Assay Technology Type Term Accession Number  
Study Assay Technology Type Term Source REF  
Study Assay Technology Platform  
Study Assay Measurement Namecell viabilityLDH release
Study Assay Measurement Name Term Accession NumberNPO_1343 
Study Assay Measurement Name Term Source REFNPO 
Study Assay File Namea_MTT-LLCPK1.xlsa_LDH-LLCPK1.xls

Study Factors

TABLE 11. Example Investigation File Study Factors Section

STUDY   FACTORS   
Study Factor Namenanoparticle sampleparticle concentrationtime of exposure
Study Factor Name Term Accession NumberNPO_1404NPO_1830NPO_1819
Study Factor Name Term Source REFNPONPONPO
Study Factor Type   
Study Factor Type Term Accession Number   
Study Factor Type Term Source REF   

 

Study Protocols

TABLE 12. Example Investigation File Study Protocols Section

...